Engineering Cell-Cell Interactions by Chemically Self-Assembled CARS
通过化学自组装 CARS 改造细胞间相互作用
基本信息
- 批准号:8986165
- 负责人:
- 金额:$ 19.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-12-12 至 2016-11-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAntibioticsAntibodiesBiological MarkersBreast Cancer CellCD3 AntigensCancer PatientCarcinomaCell CommunicationCell TherapyCell membraneCell surfaceCellsChemistryChimeric ProteinsDataDevelopmentDihydrofolate ReductaseDimerizationEngineeringEscherichia coliFDA approvedFatty AcidsFutureGenerationsGenetic EngineeringGoalsHealthImmuneIn VitroKineticsLeadLengthLibrariesLipidsMalignant NeoplasmsMembraneMethodsMethotrexateModificationMolecularMusOligonucleotidesPatientsPeptidesPharmaceutical PreparationsPhospholipidsPreparationRoleStem cellsStructureSulfhydryl CompoundsSystemT-LymphocyteTACSTD1 geneTestingTherapeuticTherapeutic UsesTimeTissuesToxic effectTrimethoprimXenograft Modelarmbasecancer cellcancer stem cellcell killingcellular engineeringchemical additionchimeric antigen receptorclinically relevantcost effectivecytotoxicityfluorophoregenetically modified cellsin vivomalignant breast neoplasmneoplastic cellprogramsrepairedsynthetic antibodiestissue regenerationtumor
项目摘要
DESCRIPTION (provided by applicant): The ability to engineer and re-program the surfaces of cells has the potential to expand and enable the therapeutic use of cell based therapies for both tissue regeneration and cancer. To achieve this goal a number of cell surface engineering approaches have been devised. Clinically, genetic engineering of cells is by far the most commonly used approach for the modification of cell surfaces. Nevertheless, the preparation of the engineered cells is time consuming, requires several sophisticated steps and can lead to long term immune toxicities. Our group has employed the power of chemically induced protein dimerization to develop a method to produce chemically self-assembled nanorings (CSANs). We have shown that two E. coli dihydrofolate reductase molecules (DHFR2) fused to a single chain antibody (scFv) or targeting peptide can be engineered to spontaneously self-assemble, upon the addition of the chemical dimerizer, bis-methotrexate (Bis-MTX), into either highly stable bivalent or octavalent synthetic antibody CSANs. Recently, using a Bis-MTX phospholipid conjugate, we have prepared CSANs that rapidly (min) and stably (days) insert into cell membranes. In addition, when a scFv targeting EpCAM, a carcinoma and cancer stem cell marker, was fused to the DHFR2 building block, our first generation anti-EpCam chemically self-assembled chimeric antigen receptors (anti-EpCAM-CS-CARs) were formed and found to direct selective Tcell cell killing of EpCAM positive breast cancer cells. A unique feature of our approach is the ability to remove the anti-EpCAM-CS-CARs from the T-cells pharmacologically with a non-toxic drug. Therefore, we propose to prepare a small library of structurally different anti-EpCAM-CS-CARs and determine their ability to stably functionalize T-cell membranes and induce cytotoxicity toward EpCam positive tumor cells both in vitro and in vivo. This preliminary data will allow us to establish the potential for chemically self-assembled chimeric antigen receptors (CS-CARs) to serve as an alternative and complementary approach for the engineering of stable, yet pharmacologically reversible, therapeutic cell-cell interactions.
描述(由申请人提供):对细胞表面进行工程化和重新编程的能力具有扩展和实现基于细胞的疗法用于组织再生和癌症的治疗用途的潜力。为了实现这一目标,已经设计了许多细胞表面工程方法。在临床上,细胞的基因工程是迄今为止最常用的修饰细胞表面的方法。然而,工程细胞的制备是耗时的,需要几个复杂的步骤,并可能导致长期的免疫毒性。我们的团队利用化学诱导蛋白质二聚化的能力开发了一种生产化学自组装纳米环(CSAN)的方法。我们证明了两个E.与单链抗体(scFv)或靶向肽融合的大肠杆菌二氢叶酸还原酶分子(DHFR 2)可以被工程化,以在加入化学二聚化剂双甲氨蝶呤(Bis-MTX)后自发地自组装成高度稳定的二价或八价合成抗体CSAN。最近,使用Bis-MTX磷脂缀合物,我们已经制备了快速(分钟)和稳定(天)插入细胞膜的CSAN。此外,当靶向EpCAM(癌和癌症干细胞标志物)的scFv与DHFR 2结构单元融合时,形成了我们的第一代抗EpCam化学自组装嵌合抗原受体(抗EpCAM-CS-CAR),并发现其指导EpCAM阳性乳腺癌细胞的选择性T细胞杀伤。我们的方法的独特特征是用无毒药物从T细胞中去除抗EpCAM-CS-CAR的能力。因此,我们提出制备结构不同的抗EpCAM-CS-CAR的小文库,并确定它们在体外和体内稳定功能化T细胞膜并诱导对EpCam阳性肿瘤细胞的细胞毒性的能力。这些初步数据将使我们能够建立化学自组装嵌合抗原受体(CS-CAR)的潜力,作为一种替代和补充方法,用于工程化稳定但不可逆的治疗性细胞-细胞相互作用。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Eradication of Established Tumors by Chemically Self-Assembled Nanoring Labeled T Cells.
通过化学自我组装的标记T细胞消除已建立的肿瘤。
- DOI:10.1021/acsnano.8b01308
- 发表时间:2018-07-24
- 期刊:
- 影响因子:17.1
- 作者:Petersburg JR;Shen J;Csizmar CM;Murphy KA;Spanier J;Gabrielse K;Griffith TS;Fife B;Wagner CR
- 通讯作者:Wagner CR
Titratable Avidity Reduction Enhances Affinity Discrimination in Mammalian Cellular Selections of Yeast-Displayed Ligands.
可滴定亲和力降低增强了酵母展示配体的哺乳动物细胞选择中的亲和力辨别力。
- DOI:10.1021/acscombsci.6b00191
- 发表时间:2017
- 期刊:
- 影响因子:0
- 作者:Stern,LawrenceA;Csizmar,CliffordM;Woldring,DanielR;Wagner,CarstonR;Hackel,BenjaminJ
- 通讯作者:Hackel,BenjaminJ
In Vivo Evaluation of Site-Specifically PEGylated Chemically Self-Assembled Protein Nanostructures.
体内特定于定位的化学自我组装蛋白纳米结构的体内评估。
- DOI:10.1021/acs.molpharmaceut.6b00110
- 发表时间:2016-07-05
- 期刊:
- 影响因子:4.9
- 作者:Shah R;Petersburg J;Gangar AC;Fegan A;Wagner CR;Kumarapperuma SC
- 通讯作者:Kumarapperuma SC
Eradication of Heterogeneous Tumors by T Cells Targeted with Combination Bispecific Chemically Self-assembled Nanorings.
- DOI:10.1158/1535-7163.mct-22-0515
- 发表时间:2023-03-02
- 期刊:
- 影响因子:5.7
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CARSTON R. WAGNER其他文献
CARSTON R. WAGNER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CARSTON R. WAGNER', 18)}}的其他基金
Anchimerically Activatable Anti-Zika/Dengue ProTides
反嵌合激活的抗寨卡/登革热 ProTides
- 批准号:
10459572 - 财政年份:2021
- 资助金额:
$ 19.11万 - 项目类别:
Anchimerically Activatable Anti-Zika/Dengue ProTides
反嵌合激活的抗寨卡/登革热 ProTides
- 批准号:
10671030 - 财政年份:2021
- 资助金额:
$ 19.11万 - 项目类别:
Anchimerically Activatable Anti-Zika/Dengue ProTides
反嵌合激活的抗寨卡/登革热 ProTides
- 批准号:
10296447 - 财政年份:2021
- 资助金额:
$ 19.11万 - 项目类别:
Targeting Effector Immune cells to Cancer with Chemically Self-Assembled Nanorings (CSANs)
使用化学自组装纳米环 (CSAN) 将效应免疫细胞靶向癌症
- 批准号:
10600820 - 财政年份:2020
- 资助金额:
$ 19.11万 - 项目类别:
Targeting Effector Immune cells to Cancer with Chemically Self-Assembled Nanorings (CSANs)
使用化学自组装纳米环 (CSAN) 将效应免疫细胞靶向癌症
- 批准号:
10347346 - 财政年份:2020
- 资助金额:
$ 19.11万 - 项目类别:
Engineering Cell-Cell Interactions by Chemically Self-Assembled CARS
通过化学自组装 CARS 改造细胞间相互作用
- 批准号:
8812196 - 财政年份:2014
- 资助金额:
$ 19.11万 - 项目类别:
相似海外基金
Can antibiotics disrupt biogeochemical nitrogen cycling in the coastal ocean?
抗生素会破坏沿海海洋的生物地球化学氮循环吗?
- 批准号:
2902098 - 财政年份:2024
- 资助金额:
$ 19.11万 - 项目类别:
Studentship
The role of RNA repair in bacterial responses to translation-inhibiting antibiotics
RNA修复在细菌对翻译抑制抗生素的反应中的作用
- 批准号:
BB/Y004035/1 - 财政年份:2024
- 资助金额:
$ 19.11万 - 项目类别:
Research Grant
Metallo-Peptides: Arming Cyclic Peptide Antibiotics with New Weapons to Combat Antimicrobial Resistance
金属肽:用新武器武装环肽抗生素以对抗抗菌素耐药性
- 批准号:
EP/Z533026/1 - 财政年份:2024
- 资助金额:
$ 19.11万 - 项目类别:
Research Grant
Towards the sustainable discovery and development of new antibiotics
迈向新抗生素的可持续发现和开发
- 批准号:
FT230100468 - 财政年份:2024
- 资助金额:
$ 19.11万 - 项目类别:
ARC Future Fellowships
DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
- 批准号:
EP/Y023528/1 - 财政年份:2024
- 资助金额:
$ 19.11万 - 项目类别:
Research Grant
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
- 批准号:
BB/Y007611/1 - 财政年份:2024
- 资助金额:
$ 19.11万 - 项目类别:
Research Grant
The disulfide bond as a chemical tool in cyclic peptide antibiotics: engineering disulfide polymyxins and murepavadin
二硫键作为环肽抗生素的化学工具:工程化二硫多粘菌素和 murepavadin
- 批准号:
MR/Y033809/1 - 财政年份:2024
- 资助金额:
$ 19.11万 - 项目类别:
Research Grant
Role of phenotypic heterogeneity in mycobacterial persistence to antibiotics: Prospects for more effective treatment regimens
表型异质性在分枝杆菌对抗生素持久性中的作用:更有效治疗方案的前景
- 批准号:
494853 - 财政年份:2023
- 资助金额:
$ 19.11万 - 项目类别:
Operating Grants
Imbalance between cell biomass production and envelope biosynthesis underpins the bactericidal activity of cell wall -targeting antibiotics
细胞生物量产生和包膜生物合成之间的不平衡是细胞壁靶向抗生素杀菌活性的基础
- 批准号:
2884862 - 财政年份:2023
- 资助金额:
$ 19.11万 - 项目类别:
Studentship
Narrow spectrum antibiotics for the prevention and treatment of soft-rot plant disease
防治植物软腐病的窄谱抗生素
- 批准号:
2904356 - 财政年份:2023
- 资助金额:
$ 19.11万 - 项目类别:
Studentship